ICU
NASDAQSeaStar Medical Holding Corporation
News25/Ratings0
Price$3.27+0.94 (+40.34%)
2026-03-182026-06-22
News · 26 weeks43-75%
2025-12-282026-06-21
Mix2590d
- SEC Filings14(56%)
- Other9(36%)
- Earnings2(8%)
Latest news
25 items- PRSeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney InjuryEnables standardized inpatient hospital billing for QUELIMMUNE® (SCD-PED) therapy Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER, June 23, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that its Selective Cytopheretic Device (SCD) therapy has received dedicated ICD-10-PCS (International Classification of Diseases, 10th Revision, Procedure Coding System) codes from the Centers for Medicare & Medicaid Services (CMS). This assi
- PRSeaStar Medical to Present at Upcoming Investor Summit ConferenceDENVER, June 22, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today that Eric Schlorff, Chief Executive Officer of SeaStar Medical, will present at the Virtual Investor Summit Conference on Wednesday, June 24th at 10:30 am Eastern Time. Interested investors can register and view the live presentation here: SeaStar Medical Events / Presentations A replay of the SeaStar Medical presentation will be available on the Company's website and can be accessed here. The replay will be available for up to 30
- SECSeaStar Medical Holding Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form 424B3 filed by SeaStar Medical Holding Corporation424B3 - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form 10-Q filed by SeaStar Medical Holding Corporation10-Q - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by SeaStar Medical Holding CorporationSCHEDULE 13G/A - SeaStar Medical Holding Corp (0001831868) (Subject)
- SECSeaStar Medical Holding Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SeaStar Medical Holding Corp (0001831868) (Filer)
- PRSeaStar Medical Reports First Quarter Financial Results and Provides Business UpdatesAdded 7 top-rated children's hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI Initiated efforts for the submission of a modular post-marketing application (PMA) Webcast today at 4:30 pm Eastern Time DENVER, May 13, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today financial results for the three months ended Marc
- SECSEC Form EFFECT filed by SeaStar Medical Holding CorporationEFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form SCHEDULE 13G filed by SeaStar Medical Holding CorporationSCHEDULE 13G - SeaStar Medical Holding Corp (0001831868) (Subject)
- SECAmendment: SEC Form S-1/A filed by SeaStar Medical Holding CorporationS-1/A - SeaStar Medical Holding Corp (0001831868) (Filer)
- PRSeaStar Medical to Report First Quarter Financial Results on May 13, 2026DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 13, 2026, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Wednesday, May 13, 2026, at 4:30 p.m. ET / 2:30 p.m. MT Webcast:The live webcast and replay can be found here. Register for the call:Preregistration is required to attend the live call and can be accessed here. A pin code and dial i
- SECSEC Form EFFECT filed by SeaStar Medical Holding CorporationEFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form EFFECT filed by SeaStar Medical Holding CorporationEFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form EFFECT filed by SeaStar Medical Holding CorporationEFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form DEF 14A filed by SeaStar Medical Holding CorporationDEF 14A - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form POS AM filed by SeaStar Medical Holding CorporationPOS AM - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form POS AM filed by SeaStar Medical Holding CorporationPOS AM - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form POS AM filed by SeaStar Medical Holding CorporationPOS AM - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSEC Form S-1 filed by SeaStar Medical Holding CorporationS-1 - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSeaStar Medical Holding Corporation filed SEC Form 8-K: Other Events8-K - SeaStar Medical Holding Corp (0001831868) (Filer)
- PRSeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival data In vitro analysis of the SeaStar Medical SCD indicates modulation of the immune response, shifting monocytes towards an anti-inflammatory, reparative phenotype SeaStar Medical hosts an industry symposium and panel discussion focused on innovation in the treatment of pediatric AKI, supporting its emerging leadership in this community DENVER, March 30, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ fai
- SECSEC Form 10-K filed by SeaStar Medical Holding Corporation10-K - SeaStar Medical Holding Corp (0001831868) (Filer)
- SECSeaStar Medical Holding Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SeaStar Medical Holding Corp (0001831868) (Filer)
- PRSeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatesAdded top-rated children's hospitals to QUELIMMUNE™ pediatric Acute Kidney Injury (AKI) customer base Completed enrollment in FDA-mandated QUELIMMUNE SAVE Post-Marketing Registry Exceeded 50% enrollment milestone in pivotal trial of SCD therapy in adult patients with AKI Advanced pipeline indications with initiation of cardio-renal clinical trial Webcast today at 4:30 pm Eastern Time DENVER, March 25, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today financial results for the three months and yea
ICU FAQ
5 questionsWhere does ICU stock trade?
SeaStar Medical Holding Corporation (ICU) is listed on NASDAQ.What sector and industry is ICU in?
SeaStar Medical Holding Corporation operates in the Health Care sector, Medical/Dental Instruments industry.When did SeaStar Medical Holding Corporation go public?
SeaStar Medical Holding Corporation (ICU) completed its IPO in 2021.What companies are similar to ICU?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare ICU side-by-side with any of them on Quantisnow.How can I track ICU on Quantisnow?
Quantisnow aggregates SeaStar Medical Holding Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ICU to receive live email and push alerts on every new disclosure.